Practice parameter [RETIRED]: a guideline for discontinuing antiepileptic drugs in seizure-free patients--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology
- PMID: 8757050
- DOI: 10.1212/wnl.47.2.600
Practice parameter [RETIRED]: a guideline for discontinuing antiepileptic drugs in seizure-free patients--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology
Comment in
-
A guideline for discontinuing antiepileptic drugs in seizure-free patients.Neurology. 1999 Jul 13;53(1):239. doi: 10.1212/wnl.53.1.239. Neurology. 1999. PMID: 10408576 No abstract available.
Similar articles
-
Practice parameter [RETIRED]: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology. 1998 Oct;51(4):944-8. doi: 10.1212/wnl.51.4.944. Neurology. 1998. PMID: 9781510 No abstract available.
-
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.Neurology. 2005 Jan 11;64(1):172-4; author reply 172-4. Neurology. 2005. PMID: 15642936 No abstract available.
-
Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.Epilepsia. 1998 Nov;39(11):1226-31. doi: 10.1111/j.1528-1157.1998.tb01316.x. Epilepsia. 1998. PMID: 9821989 No abstract available.
-
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.Neurology. 2004 Apr 27;62(8):1252-60. doi: 10.1212/01.wnl.0000123693.82339.fc. Neurology. 2004. PMID: 15111659 Review.
-
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.Neurology. 2004 Apr 27;62(8):1261-73. doi: 10.1212/01.wnl.0000123695.22623.32. Neurology. 2004. PMID: 15111660 Review.
Cited by
-
Oxcarbazepine: an update of its efficacy in the management of epilepsy.CNS Drugs. 2001;15(2):137-63. doi: 10.2165/00023210-200115020-00005. CNS Drugs. 2001. PMID: 11460891 Review.
-
Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review.Epilepsia Open. 2023 Jun;8(2):371-385. doi: 10.1002/epi4.12695. Epub 2023 Feb 14. Epilepsia Open. 2023. PMID: 36693718 Free PMC article.
-
Seizure disorders: Part 2. Treatment.West J Med. 2001 Sep;175(3):184-8. doi: 10.1136/ewjm.175.3.184. West J Med. 2001. PMID: 11527850 Free PMC article. Review. No abstract available.
-
Patient Perspectives on Antiseizure Medication Discontinuation: A Mixed-Methods Exploration of Risk Perception, Tolerance, and Counseling.Neurol Clin Pract. 2025 Jun;15(3):e200475. doi: 10.1212/CPJ.0000000000200475. Epub 2025 May 2. Neurol Clin Pract. 2025. PMID: 40336929
-
Stopping antiepileptic drugs: when and why?Curr Treat Options Neurol. 2010 Sep;12(5):434-42. doi: 10.1007/s11940-010-0083-8. Epub 2010 Jun 26. Curr Treat Options Neurol. 2010. PMID: 20730110 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical